Advertisment CMED
Home Print this page Email this page Users Online: 55
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
ORIGINAL ARTICLE
Year : 2012  |  Volume : 1  |  Issue : 4  |  Page : 206-211

Feasibility of Simultaneous Integrated Boost Intensity Modulated Radiotherapy treatment plans in patients with localized carcinoma prostate


Department of Radiotherapy, Post Graduate Institute of Medical Education and Research, Chandigarh, India

Correspondence Address:
Anshuma Bansal
Department of Radiotherapy, Post Graduate Institute of Medical Education and Research, Chandigarh-160 012
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/2278-0513.106258

Rights and Permissions

Aim: To dosimeterically analyze Simultaneous Integrated Boost Intensity Modulated Radiotherapy (SIB-IMRT) treatment plan in prostate cancer patients, in terms of target coverage and dose to organs at risk. To determine radiobiological effect of this technique on target and normal tissues using Tumor Control Probability (TCP) and Normal Tissue Complication Probability (NTCP). Materials and Methods: Twenty patients with localized prostate cancer were enrolled. In all, the target consisted of PTV P + SV (Prostate and seminal vesicles) and PTV LN (lymph nodes) where PTV refers to planning target volume and the critical structures included: bladder, rectum, small bowel, penile bulb and bilateral femoral heads. For all patients, SIB IMRT plan was created. The prescription dose to the PTV P + SV is 74 Gy delivered in 27 fractions over 5.5 weeks and the dose to PTV LN is 54 Gy delivered in 27 fractions over 5.5 weeks. The treatment plan was analyzed in terms of their dose-volume histograms, target volume covered by 95% of the prescription dose (V 95%), and maximum and mean structure doses (Dmax and Dmean). Also an analysis was done on TCP and NTCP obtained with the plan. NTCP was calculated by Lyman Kutcher Burman (LKB) model. Results: All the critical structures received doses within the dose constraints specified for the SIB IMRT plan. The volume of rectum and bladder receiving 65 Gy or more (V > 65 Gy) was 18.23% and 24.05%. The mean doses to both bladder and rectum were 59 ± 3 Gy and 57 ± 4 Gy respectively. NTCP of 0.01 ± 0.02% for bladder, 4.31 ± 2.61% for rectum and 8.25 ± 7.98% for small bowel was achieved with SIB-IMRT plans. Conclusions: SIB-IMRT is dosimetrically and radiobiologically feasible treatment technique for prostate cancer IMRT.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed3385    
    Printed93    
    Emailed0    
    PDF Downloaded184    
    Comments [Add]    

Recommend this journal